CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ecological governance.
Beam Therapeutics Inc. buy thesis: base-editing gene therapy leaders, risto-cel & BEAM-302 catalysts, strong cash runway.
In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...
One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand treatment to others.
February 25, 2026 marks one year since KJ, an infant born with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, became the world's first person to receive a personalized CRISPR-based gene ...
Learn more about the cutting-edge technology that enables 3D printing inside living cells and what that means for the ...
In a world where agriculture is confronted with unprecedented challenges—such as climate variability, emerging pathogens, and ...
"Gene editing takes centre stage in FDA’s new rare disease approval pathway" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
In a world where agriculture is confronted with unprecedented challenges—such as climate variability, emerging pathogens, and soil degradation, in addition ...
FDA Commissioner Marty Makary says the agency wants to remove barriers for patients suffering from rare genetic conditions.
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results